Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s434582 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Jiandong Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, People's Republic of China. Hauptthemen laut MEDLINE: Melanoma, Neoplasms, Skin Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, People's Republic of China.
- Department of Pharmacy, Third Affiliated Hospital of Naval Medical University, Shanghai, People's Republic of China.
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
- Shanghai Engineering Research Center of External Chinese Medicine, Shanghai, 200443, People's Republic of China.
ORCID-Profile: Zongguang Tai, Zhongjian Chen
Zitieren
APA
Wang, J., Ma, J., Tai, Z., Li, L., Zhang, T., Cheng, T., Yu, J., Zhu, Q., Bao, L., & Chen, Z. (2023). Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s434582
Vancouver
Wang J, Ma J, Tai Z, Li L, Zhang T, Cheng T, et al. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s434582
BibTeX
@article{Wang2023,
author = {Wang, Jiandong and Ma, Jinyuan and Tai, Zongguang and Li, Lisha and Zhang, Tingrui and Cheng, Tingting and Yu, Junxia and Zhu, Quangang and Bao, Leilei and Chen, Zhongjian},
title = {Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s434582}
}
EUVIMED